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BIOMEDICAL TREATMENT FOR PDD-NOS; A VALID MEDICAL EXPENDITURE. 
INTRODUCTION 
Recent movements in health insurance reform have moved away from actuarial fairness, 
which accesses the cost of insurance according to the individual risk of sickness, and towards a 
system based on social solidarity, which distributes insurance cost evenly across society.
1
  
Providing an individual with access to universal healthcare, will lower health care costs because 
services will be easily accessible without lapses in care.
2
 Expanding health coverage will protect 
society from risks, which are undiscriminating, such as unpredictable and severe lifelong 
disorders such as Autism.
3
 Seamless health insurance coverage for an individual’s entire life has 
yet to be achieved, but providing more comprehensive coverage for services needed to treat 
lifelong disorders like autism may be more readily achievable. 
To date, susceptibility of having a child with Autism is relatively undeterminable and as 
a result, society as a whole is equally vulnerable to this lifelong disorder, and the expensive 
                                                          
1
 Hoffman, S. Unmanaged Care: Towards moral fairness in health care coverage. Available at, 
http://www.ncbi.nlm.nih.gov/pubmed/15214342. See also, Tom Baker. Health Insurance, Risk, and Responsibility 
After the Patient Protection and Affordable Care Act. University of Pennsylvania law Review. Available at, 
http://www.pennumbra.com/issues/pdfs/159-6/Baker.pdf. 
2
 Deborah Stone. The Struggle for the Soul of Health Insurance. Brandeis University. The Journal of Health 
Politics, Policy and law. Available at, http://myweb.shu.edu/bbcswebdav/pid-2452936-dt-content-rid-
4320224_2/courses/2012_SPRING_HLTH7408MM/Stone%20Struggle%20for%20the%20Soul%20of%20HI%209
3%20excerpt.pdf (Positing that the most beneficial universal health coverage  means coverage lasting for the entire 
lifespan of the individual). 
3
 Id. 
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treatments it requires.
4
 Thus, health insurance coverage should be expanded to provide 
comprehensive access to treatments for autism because of society’s collective vulnerability to 
this particular illness. Insurance providers have avoided covering Autism treatments because 
treating Autism is a heavy financial burden. Treatment can run as much as $72,000 for one child 
per year, or over 3.2 million over the course of that child’s lifespan.5 Still, allocating this 
expense evenly across society is the most reasonable and fair approach because we cannot yet 
determine exactly who will have a child with Autism and should one have a child with this 
lifelong disorder, that person will want easy and comprehensive access to treatment. Further, 
implementing a system, which allocates the expense for Autism treatment evenly will only 
slightly increase insurance rates overall.
6
 Importantly, mandating broader insurance coverage for 
treating Autism will result in larger gains earlier in the child’s development, which will result in 
higher levels of independent living during the child’s adult life, thus, lowering society’s burden 
                                                          
4
 Looking at family history may be indicative of a likelihood of having a child with Autism Spectrum Disorder 
(ASD). Genetics may play a role in being able to determine if one is more likely to have a child with Autism. For 
example,  Parents with one child with autism are more likely to have autistic children in the future. 
http://autismnow.org/at-home/family/multiple-children-with-autism/. See also, Autism and Genetics. The Tech 
Museum of Innovation. Available at, http://genetics.thetech.org/original_news/news49 (“If you have one child with 
autism, the risk for the next child is only 2-6% … if you have two children with autism, the chances that the third 
will be autistic are around 35%”). See also, John Constantino. Sibling Recurrence and the Genetic Epidemiology of 
Autism. Available at, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970737/ (families with autistic children had 
an occurrence of ASD in a sibling 10.9% of the time and “20% of non ASD affected siblings had a history of 
language delay half of which exhibited autistic qualities of speech.”).   
5
 Anna Satz. Overcoming Fragmentation in Health and Disability Law. 60 Emory L. J. 277 (2011). Health insurance 
coverage based on universal vulnerability to illness. See also, Data & Statistics. Center for Disease Control. 
Avaiable at, http://www.cdc.gov/ncbddd/autism/data.html. (estimates behavioral therapies to cost between 40 and 
60 thousand per year and medical costs between 4 and 6 thousand per year for a child with ASD). 
6
 Autism. Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/autism/data.html. See, Walecia 
Konrad. Dealing With the Financial Burden of Autism. The New York Times. Available at, 
http://www.nytimes.com/2010/01/23/health/23patient.html?_r=1&pagewanted=all. 
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of supporting adults with Autism, through programs such as SSI
7
 or SSDI.
8
 Specifically, 
comprehensive early intervention programs lessen the average cost of care, which is 3 to 5 
million per child, by two thirds.
9
 Important to creating a comprehensive treatment plan for 
autism is incorporating innovative approaches, such as biomedical treatment. 
Autism is a neurological disorder resulting in global delays in a child’s adolescent 
development.
10
 Autism detrimentally affects a child’s physical, mental, and social capabilities 
and significantly impairs a child’s daily functioning.11 If a child has a speech delay or disorder 
and physical coordination issues, as well as, an aversion to typical social behavior for a child of 
like age, the combination of all of those factors may indicate the child has Autism Spectrum 
Disorder (ASD).
12
 Autism is a spectrum disorder, meaning that children diagnosed with ASD 
will have varying severity of their impairments.
13
 A child with the most severe diagnosis of 
Autism suffers from substantial barriers in all three areas of development; physical, mental, and 
                                                          
7
 “The Social Security Income (SSI) program pays benefits to disabled adults and children who have limited income 
and resources.” U.S. Social Security Administration. Available at, http://www.ssa.gov/pgm/ssi.htm. 
8
 Social Security and Supplemental Security Income Disability Programs. U.S. Social Security Administration. 
Available at, http://www.ssa.gov/disability/ (“The Social Security and Supplemental Security Income disability 
programs are the largest of several Federal programs that provide assistance to people with disabilities. While these 
two programs are different in many ways, both are administered by the Social Security Administration and only 
individuals who have a disability and meet medical criteria may qualify for benefits under either program.”). 
9
 See, The Budget Crisis. Autism Society. Available at, http://www.autism-society.org/get-involved/the-budget-
crisis.html. 
10
 Autism Fact Sheet. National Institute of Neurological Disorders and Stroke. National Institutes of Health. Last 
updated October 17, 2012. Available at, http://www.ninds.nih.gov/disorders/autism/detail_autism.htm. 
11
  Autism Spectrum Disorders (ASDs). Centers for Disease Control and Prevention. Available at, 
http://www.cdc.gov/NCBDDD/autism/facts.html. 
12
 Autism Fact Sheet. National Institute of Neurological Disorders and Stroke. National Institutes of Health. Last 
updated October 17, 2012. Available at, http://www.ninds.nih.gov/disorders/autism/detail_autism.htm 
13
 Id. 
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emotional.
14
  Alternatively, a diagnosis of Asperger’s is still considered ASD but includes 
children with higher cognitive ability, sometimes with exceptional ability in a particular area of 
study, but with rather significant social impairments.
15
 This article will focus on a third ASD 
diagnosis called Pervasive Developmental Disorder – Not Otherwise Specified (PDD-NOS), 
which typically includes children suffering from a combination of two impairment categories.
16
 
Typically children diagnosed with PDD-NOS are also considered “high functioning.”17  
This article focuses on PDD-NOS because these children are high functioning, and have 
the potential to become full independent significantly reducing the number of adults with ASD 
requiring expensive treatment. Children with PDD-NOS are a subset of the total population of 
children with ASD, and while biomedical treatment will help all children with ASD to progress, 
biomedical treatment in combination with other services for children with PDD-NOS could 
potentially result in that child becoming fully recovered, or no longer classified as ASD or 
needing special services and treatments.
18
 
                                                          
14
 Autism Spectrum Disorders (ASDs). Centers for Disease Control and Prevention. Available at, 
http://www.cdc.gov/NCBDDD/autism/facts.html. 
15
 Id. 
16
 What is PDD-NOS? Autism Speaks Inc. Available at, http://www.autismspeaks.org/what-autism/pdd-nos. 
17
 Id. 
18 See, Incidence of Autism. Autism-Help.org. Available at, http://www.autism-help.org/autism-incidence-
increase.htm. See also,  Study suggests kids can ‘recover’ from autism. Copyright 2009 The Associated Press. 
Avaialble at, http://www.msnbc.msn.com/id/30645770/ns/health-mental_health/t/study-suggests-kids-can-recover-
autism/#.UPXlOHfn-So. In 2007 PDD-NOS was thought to be more prevalent than a diagnosis of sever autism, and 
thus by providing expanded treatments that can help recover children with pdd-nos and allow them to be fully 
functioning independent adults, we can significantly reduce the overall health insurance costs for autism treatments 
within the autism community. 
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Treatment for PDD-NOS does not necessitate the most intense therapies reserved to treat 
severe autism, such as ABA therapy.
19
 Nonetheless, children with PDD-NOS do benefit from a 
combination of services now generally used to treat ASD’s such as Speech Therapy (ST), 
Occupational Therapy (OT), and Physical Therapy (PT).
20
 For the most effective treatment these 
traditional services should be implemented in conjunction with, other less traditional therapies.
21
 
There is no prevention or a cure for autism, but early intervention with a combination of various 
therapies has shown to significantly reduce the symptoms and impairments inflicting children 
with PDD-NOS.
22
 Particularly, many in the autism community have advocated that including 
biomedical treatment as a part of an early intervention program is beneficial for children with 
PDD-NOS.
23
  
Biomedical treatment for autism reduces symptoms associated with one's inability to 
tolerate environmental stressors.
24
 Such treatments seek to treat the person individually and 
holistically, addressing deficits with medical or chemical means.
25
  Using biomedical treatments 
to alleviate sensory processing impairments include treating food sensitivities by employing 
                                                          
19
 Autism Spectrum Disorders, Treatment. Center for Disease Control. May 24, 2012. Available at, 
http://www.cdc.gov/ncbddd/autism/treatment.html. 
20
 Id.  
21
 Id. 
22
 Id. 
23
 Id. See also, Why Should I Consider Biomedical Treatment for Autism? Treating Autism. Available at, 
http://www.treatingautism.co.uk/why-biomedical/. 
24
 Kenneth Bock. Integrative Medicine. Rhinebeck Health Services. Available at, 
http://www.rhinebeckhealth.com/rhc/integ_med.php. 
 
25
 Id. 
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special diet plans, such as gluten free and casine free diets.
26
 Another aspect to biomedical 
treatment is treating vitamin deficiencies with supplements, which address deficiencies for 
example in amino acids and detoxifying the body of metals.
27
  Biomedical treatment can also 
include using pharmaceuticals to treat symptoms of hyperactivity.
28
 Problems with the digestion 
system are prevalent in children with ASD.
29
 There are strong indicators that a healthy digestive 
system allows for proper cognitive function referred to as the mind-gut connection.
30
 The goal of 
biomedical treatment is to alleviate digestive problems attributed to children with ASD reducing 
many of the symptoms causing social and cognitive impairments.
31
  
Unfortunately, despite clinical case studies indicating the positive impact that biomedical 
approaches have on ASD’s, insurance providers have managed to exclude coverage for such 
treatment(s) claiming them to be complementary or alternative treatment (CAM) and not 
medically necessary.
32
 Yet, hope is not lost. Further research is currently underway, which will 
ultimately prove biomedical treatment is effective and an essential part of an effective treatment 
                                                          
26
 Holly Bortfeld. GFCFSF Diet on a Budget. Talk About Curing Autism. July 7, 2010. Available at, 
http://www.tacanow.org/family-resources/gfcfsf-diet-on-a-budget/. 
27
 James B. Adams. Summary of Biomedical Treatment for Autism. Autism Society. http://www.autism-
society.org/living-with-autism/treatment-options/summary-of-biomedical.html. 
28
 Id. 
29
Autism and GI Disorders. Autism Speaks. Available at, http://www.autismspeaks.org/what-
autism/treatment/treatment-associated-medical-conditions/gi-disorders. 
30
 The Gut-Brain Connection. Harvard Health Publication. March 27, 2012. 
http://www.health.harvard.edu/healthbeat/the-gut-brain-connection. 
31
 James B. Adams. Summary of Biomedical Treatment for Autism. Autism Society. http://www.autism-
society.org/living-with-autism/treatment-options/summary-of-biomedical.html. 
32
 What Is Complementary and Alternative Medicine? National Center for Complementary and Alternative 
Medicine. NCCAM Pub No.: D347 Date Created: October 2008 Last Updated: July 2011 
http://nccam.nih.gov/health/whatiscam. 
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plan for ASD’s.33  With substantial empirical evidence, the judiciary and legislature alike will be 
compelled to require insurance providers to cover the cost of such proven beneficial treatments. 
One hurdle in requiring insurance coverage for biomedical treatment is that each child 
responds differently to treatment.
34
 For that reason, finding the appropriate combination of 
services for one child requires significant amounts of time and money. Subsequently, insurance 
providers are reluctant to cover treatment for autism. Previously, insurance providers fought to 
exclude treatments such as speech, occupational therapy, and physical therapy, claiming they are 
not medically necessary for the treatment of ASD’s, but these treatments are now required to be 
covered.
35
 Many states have continued with insurance reform and now have insurance mandates 
requiring Applied Behavioral Therapy (ABA) to be covered for treatment of severe Autism, 
which was also vehemently opposed by insurance providers.
36
 This national trend towards 
providing more coverage for ASD’s suggests that biomedical treatment, despite having yet to be 
required under coverage, will have a place as a covered therapy in the near future.
37
  States 
                                                          
33
 See, Study to Explore Early Development (SEED). Centers for Disease Control and Prevention. Available at, 
http://www.cdc.gov/ncbddd/autism/seed.html. See also, Autism Speaks Announces $6.9 Million in New 
Biomedical Research Grants. Autism Speaks. Available at, http://www.autismspeaks.org/about-us/press-
releases/autism-speaks-announces-69-million-new-biomedical-research-grants. See also, Yale School of Medicine. 
Yale Child Study Center. Available at, http://medicine.yale.edu/childstudy/autism/research. 
34
 Pervasive Developmental Disorders Information Page. National Institute of Neurological Disorders and Stroke. 
National Institutes of Health. Available at, http://www.ninds.nih.gov/disorders/pdd/pdd.htm. 
35
 29 U.S.C.A. § 1185a (West). See also, Angela Barner, Unlocking Access to Insurance Coverage for Autism 
Treatment, 6 J.L. Econ. & Pol'y 107 (2009). (Policy established in a settlement from Hatch v. Blue Cross Blue 
Shield of Minnesota “entitled Pervasive Development Disorders: Identification, Evaluation, and Treatment, defines 
pervasive developmental disorders (PDD) to include autism.”). 
36
 MaryAnne Lindeblad. Health Care Authority Approves ABA Therapy for Medicaid Children Diagnosed with 
Autism. Washington State Health Auhtority. Available at, http://www.hca.wa.gov/news_release/health-care-
authority-approves-aba-therapy-for.html. See also, Paul Frysh. Moving Out of State to get Autism Treatment. Cnn. 
Available at, http://www.cnn.com/2010/HEALTH/09/17/autism.aba.legislation/index.html. 
37
 State Initiatives. Autism Speaks. Available at, http://www.autismspeaks.org/advocacy/states. 
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should mandate insurance providers to cover biomedical treatment for children with ASD, 
because the treatment is beneficial and safe. Expanding insurance coverage will provide the 
child and their family with a better quality of life, and will also reduce the symptoms of their 
impairments allowing them to reach fuller potential.  
Autism is a serious national health concern. Federal and state governments both support 
research on risk detection, prevention, and ultimately a cure.
38
 Current treatments for Autism 
may only be effective for a small subset of the ASD population, which raises conflict over who 
should share in the cost.  While ASD children and their families may only be a small subset of 
society, the potential for Autism to occur in the majority of the population is on the rise, thus 
more expansive insurance coverage for ASD treatments is necessary. Specifically, as innovative 
treatment modalities for ASD’s are discovered and made available, the conflict over proper 
allocation of costs will require legislative and judicial intervention. 
Mandated access to biomedical treatment for children with ASD will require a sustained 
effort at insurance reform. Assessing the benefits of biomedical treatment for children diagnosed 
with PDD-NOS involves examining the negative impact of excluding this treatment from health 
insurance coverage, the benefits to mandating private insurance coverage for biomedical 
treatments for Autism, and possible approaches advocates can use when attempting to obtain 
coverage for children with ASD. Part I provides an overview of Autism, its impact on families 
and society, and various treatment modalities. Part II provides an overview of statistical data 
which shows the benefits of a biomedical approach to treating ASD’s. Part III discusses the two 
main positions insurance providers use to exclude biomedical treatment for ASD. Part IV 
                                                          
38
 National Database for Autism Research. National Institutes of Health. Available at, http://ndar.nih.gov/. See also, 
NIH Awards $100 Million in Autism Research Grants Funded by CARA. Autism Speaks. Available at, 
http://www.autismspeaks.org/news/news-item/nih-awards-100-million-autism-research-grants-funded-cara. 
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presents responses to the insurance provider’s positions for those advocating for insurance 
coverage for biomedical treatment. Part V proposes possible options for insurance mandates 
requiring coverage for biomedical treatment for ASD’s. Part VI concludes this papers purpose, 
which is to advocate for the expansion of private insurance coverage to include biomedical 
treatment for PDD-NOS.  
I. AUTISM DEFINED. 
Autism is a neurological disorder thought to be caused by a biological predisposition to 
Autism (genetic abnormality), which is triggered or enhanced by environmental factors, which 
result in a disruption in the neurological development during early prenatal stages.
39
 There is 
still unrest as to the exact cause of Autism, but the effects are known. Autism is a lifelong 
disorder that causes global developmental delays.  Children with ASD have physical, mental, 
and social impairments, which can significantly limit their daily living capabilities.
40
 Onset can 
be detected as early as infancy such as an infant unresponsive to social stimulus and failing to 
meet typical developmental milestones. Alternatively, infants may progress normally until 
around 15 – 24 months and then either stop progressing further (usually the case with a higher 
functioning diagnosis), or they can completely regress to infantile like behavior (typically 
associated with a more severe autistic diagnosis), both of which are also indicators of ASDs.
41
  
Obtaining an official diagnosis for Autism usually requires an analysis of the history of the child 
and family, as well as, a series of tests conducted by a neurologist or a pediatric 
                                                          
39
 Autism Fact Sheet. Office of Communications and Public Liaison. National Institute of Neurological Disorders 
and Stroke. Last updated March 20, 2012. http://www.ninds.nih.gov/disorders/autism/detail_autism.htm 
40
 Id. 
41
 Id. 
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neuropsychologist.
42
 The neuropsychologist will also access the child’s personal capabilities 
according to the DSM-IV.
43
  ASDs are generally separated by three main categories previously 
discussed, autism (most severe), PDD-NOS (less severe), or Asperger’s (usually high 
functioning).
44
 Those suffering the most severe impairments typically have substantial barriers 
in all three areas such as physical limitations effecting daily living like immature walking style 
or low muscle tone, lower mental capacity, limited memory retention or limited comprehension 
ability, and social limitations such as inability to communicate verbally, extreme behavioral 
episodes, and rapid movement of hands, legs, or arms.
45
  Children who display the above 
symptoms are diagnosed with Autism.
46
 Children with these severe limitations have proven to 
progress in their development through intense early intervention.  Unfortunately, even with a 
rigorous course of treatment these children will likely remain rather dependent on caregivers 
throughout their lives.
47
 
Alternatively, a diagnosis of Asperger’s is an ASD but is reserved for children with 
higher cognitive ability, sometimes with exceptional ability in a particular area of study, but 
                                                          
42
 Autism Spectrum Disorders (ASDs) Screening and Diagnosis. Center for disease Control and Prevention. 
Available at, http://www.cdc.gov/ncbddd/autism/screening.html. 
43
 Diagnostic Criteria. Centers for Disease Control and Prevention. Available at,  
http://www.cdc.gov/ncbddd/autism/hcp-dsm.html. 
44
 Autism Spectrum Disorders (ASDs) Facts. Center for disease Control and Prevention. Available at, 
http://www.cdc.gov/ncbddd/autism/facts.html. 
45
 Angela Barner, Unlocking Access to Insurance Coverage for Autism Treatment, 6 J.L. Econ. & Pol'y 107 (2009). 
See also, Autism Symptoms. Mayo Clinic. Available at, 
http://www.mayoclinic.com/health/autism/DS00348/DSECTION=symptoms. 
46
 Id. 
47
 Adults with Autism. National Alliance on Mental Illness. Available at, 
http://www.nami.org/Template.cfm?Section=Helpline1&Template=/ContentManagement/ContentDisplay.cfm&Co
ntentID=66015. 
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with rather significant social impairments resulting in an inability to acquiesce to social norms 
such as hygiene, make eye contact, and often fail to develop empathy.
48
  Children with mild 
Asperger’s will often go undiagnosed and even those with more intense Asperger’s symptoms 
will often go without treatment because children and adults with Asperger’s are given social 
acceptance because they are generally able to achieve academic achievement.
49
  A third 
diagnosis on the Autism Spectrum is Pervasive Developmental Disorder, will be the focus of 
this article. 
A. PERVASIVE DEVELOPMENTAL DISORDER (PDD-NOS) DISTINGUISHED. 
“Having autism can be extremely hard. However, having high-functioning autism can sometimes 
be even harder. [For example,] when a high-functioning autistic person communicates with a 
stranger, oftentimes the stranger doesn’t realize the person has a disability; [therefore], I’ve been 
looked upon as odd, scared, and sometimes even stupid. My name is Russell Lehmann; I have 
high-functioning autism.”50   
 
A child diagnosed with Pervasive Developmental Disorder – Not Otherwise Specified 
(PDD-NOS), suffers from a combination of two impairment categories.
51
 The impairments of a 
child with PDD-NOS are less disabling than a more severe Autism diagnosis and children with 
PDD-NOS are usually considered high functioning.
52
 A child with PDD-NOS is more aware of 
people and situations around them, and thus, will be able to interact with others more 
                                                          
48
 Asperger Syndrome Signs and Symptoms. KidsHealth.org. Available at, 
http://kidshealth.org/parent/medical/brain/asperger.html#. 
49
 Id. 
50
 Russell Lehmann. The Poet. Available at, https://www.squag.com/696/. See also, Russell Lehmann. Inside Out. 
Available at, http://www.autisticpoet.com/bio.php. 
51
 Asperger’s Syndrome. Autism Society. Available at, http://www.autism-society.org/about-autism/aspergers-
syndrome/. 
52
 Walker DR, Thompson A., Zwaigenbaum L., Golderberg J., Bryson SE, Mahoney WJ., Strawbridge CP, and 
Szatmari P. Specifying PDD-NOS: a comparison of PDD-NOS, Asperger Syndrome and Autism. Available at, 
http://www.ncbi.nlm.nih.gov/pubmed/14726723. 
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regularly.
53
 Still, as expressed by Russell Lehmann above children with PDD-NOS will 
experience limitations to such interactions.
54
 Even within a diagnosis of PDD-NOS there is a 
wide range of impairment levels. Children with PDD-NOS may end up with significantly 
limited functional ability in society as adults. Thus, establishing a comprehensive early 
intervention plan is important for treating PDD-NOS.
55
 Other children with PDD-NOS, typically 
those who receive the right combination of services early in their development, can become 
rather independent as adults; working, marrying, and having children of their own.
56
 One barrier 
to receiving early treatment is that children with PDD-NOS are often misdiagnosed with ADHD 
or even Bi-Polar disorder because some symptoms for these very different disorders manifest 
themselves similarly in children with PDD-NOS.
57
 Additionally, some children do not receive 
early intervention because they are not diagnosed with PDD-NOS occasionally because parents 
and doctors chose to wait and see if the child grows out of the symptoms on their owm.
58
 
Importantly, many children are not receiving appropriate and comprehensive early intervention 
                                                          
53
 Diagnostic Classifications. Autism Society. Available at, http://www.autism-society.org/about-
autism/diagnosis/diagnostic-classifications.html. 
54
 Russell Lehmann. The Poet. Available at, https://www.squag.com/696/. See also, Russell Lehmann. Inside Out. 
Available at, http://www.autisticpoet.com/bio.php. 
55
 Autism. American Academy of Child and Adolescent Psychiatry. Autism Research Center. Available at, 
http://www.aacap.org/cs/autism_resource_center/faqs_on_autism. 
56
Autism Spectrum Disorder Relationships and Sexuality. Centre for Autism. Avialable at, 
https://www.middletownautism.com/fs/doc/publications/mca-booklet-0005-wlink.pdf. 
57
 Kenneth Bock and Cameron Stauth.  Healing the New Childhood Epidemics. 2008 Ballantine Books Trade. 
Random House, Inc. New York, New York. 
58
 Pervasive Developmental Disorder. Emory University. Available at, 
http://www.psychiatry.emory.edu/PROGRAMS/autism/pdd.html#3. 
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to help them progress because the treatments they need are not being covered by insurance 
providers.
59
 
B. WITHOUT A CURE, WHAT TREATMENTS CAN BE USED TO REDUCE THE BLIGHTING 
SYMPTOMS OF AUTISM? 
The most basic treatments for ASD include the combination of three services abbreviated 
as ST, OT, and PT. Speech therapy (ST) is best provided multiple times per week with 
individual and group sessions.
60
 Many children with ASD require ST for improvements in 
articulation, chewing and swallowing, help with auditory processessing, as well as, 
categorization of words and sounds to provide them with skills so they can better involve 
themselves in general conversation.
61
 Additionally, group speech therapy sessions teach peer 
conversational skills and techniques such as not cutting someone off, using proper eye contact, 
and recognizing when to end the conversation.
62
 Speech therapy for a child with ASD is critical 
to their overall development as our academic system is heavily dependent on language 
acquisition.
63
  
Another common course of treatment for ASD is Occupational Therapy (OT). OT 
improves fine motor skills like learning how to properly use a pencil and scissors or button 
                                                          
59
 See section IV. PRIVATE INSURANCE PROVIDER’S STRONGEST ARGUMENTS FOR EXCLUDING BIOMEDICAL 
TREATMENT FROM COVERAGE on page 24. 
60
 See, Isa Marrs. Speech and Language Therapy. Available at, http://www.speechlanguagefeeding.com/speech-
language-therapy-westchester/.  
61
 Id. 
62
 Id. 
63
 See also, Communication for a Liftime. American Speech-Language-Hearing Association. Available at, 
http://www.asha.org/public/. 
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clothing, which requires hand strengthening exercises.
64
 OT also helps gross motor skills, such 
as overall planning of body movement and awareness of one’s body in space, ability to sit in a 
chair plus endurance to sit upright in a chair or the ability to stand independently without leaning 
on someone or something without throwing one’s body on the floor for sensory stimulation.65 
Using OT to address sensory processing issues significantly reduces many of the social 
impairments children with ASD exhibit, which prevent them from connecting with their peers.
66
 
Specifically, this OT approach addresses with dynamic equilibrium issues and teaches 
techniques to the child to help them ease over or under stimulation issues.
67
 This approach has 
proven to reduce “stimming,” or rapid body movements, which result in social isolation, and 
also reduces symptoms similar to those exhibited with ADHD, which is the reason for much 
misdiagnosis.
68
 Unfortunately, OT for sensory processing is only offered by private OT clinics, 
not by public schools, and is similarly not covered by private health insurance providers.
69
 
Physical therapy (PT) for ASDs addresses low muscle tone, toe walking and the like.
70
 
Providing PT to a child with ASD can help to lengthen their stride while walking, increase their 
running speed, balance and coordination for riding a bike, develop their muscle strength for 
                                                          
64
 Sue Seiler. Kidabilities. Copyright 2007. Available at, http://www.kidabilities.com/services.htm. 
65
 Id. 
66
 Id. 
67
 Id. 
68
 See, Sue Seiler. Kidabilities. Copyright 2007. Available at, http://www.kidabilities.com/faqs.htm. 
69
 Florence Clark. Essay: The Current Status of Sensory Integration Therapy. AOTA Blogs. August 7, 2012. 
http://otconnections.aota.org/aota_blogs/b/aota_presidential_blog/archive/2012/08/07/essay-the-current-status-of-
sensory-integration-therapy.aspx. 
70
 See, Patient Care Overview. Kennedy Krieger Institutte. Available at, http://www.kennedykrieger.org/patient-
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sitting, standing, rolling kicking, and teach them how to catch and throw a ball properly.
71
 It is 
imperative that children with ASD receive PT as it is essential to their daily lives, allowing them 
to participate in more activities with their peers and improving their overall quality of life.
72
 
Further, regular Behavioral therapy/psychological counseling is beneficial to children 
with ASD teaching them skills necessary to understand and identify their own emotions and 
show empathy to others.
73
 Through psychological counseling children with ASD learn how to 
better deal with the severe stress, depression, and anxiety, which are prevalent will experience 
throughout their lives, thus reducing many of the symptoms, induced during stress.
74
 
Additionally, Applied Behavioral Therapy (ABA) is used for children with the most 
severe impairments.
75
 This is a micro-approach, which breaks down each essential life skill into 
multiple steps that are innate to most children but need to be taught to children on the 
spectrum.
76
 This repetitive and basic approach has proven significantly effective and allows 
even the most severely impaired children to begin interaction with the world around them, and 
                                                          
71
 See, Treatments & Therapies. Autism Speaks. Available at, http://www.autismspeaks.org/family-services/tool-
kits/100-day-kit/treatments-therapies. 
72
 Treatment & Interventions. Southwest Autism Research & Resource Center. Available at, 
http://autismcenter.org/treatment_interventions.aspx#q5. 
73
 See, ADHD Autism Psycholigical Service and Advocacy. Available at, 
http://www.aapsa.net/Website/Team/Staff.aspx. See also, Autism Therapists in Massachusetts (MA). Psychology 
Today. http://therapists.psychologytoday.com/rms/prof_results.php?state=MA&spec=167. 
74
 Lisa Jo Rudy. What is Psychology and How does it relate to Autism? Autism Spectrum Disorders. About.com. 
Updated May 17, 2010. Available at, http://autism.about.com/od/autismtherapy101/a/psychautism.htm. 
75
 Autism Spectrum Disorders, Treatment. Center for Disease Control. May 24, 2012. Available at, 
http://www.cdc.gov/ncbddd/autism/treatment.html. 
76
 MaryAnne Lindeblad. Health Care Authority Approves ABA Therapy for Medicaid Children Diagnosed with 
Autism. Washington State Health Auhtority. Available at, http://www.hca.wa.gov/news_release/health-care-
authority-approves-aba-therapy-for.html. See also, Paul Frysh. Moving Out of State to get Autism Treatment. Cnn. 
Available at, http://www.cnn.com/2010/HEALTH/09/17/autism.aba.legislation/index.html. 
Harper 16 
 
teaches them basic functioning skills like how to hold a spoon in order to feed themselves.
77
  
Once a child begins to respond positively to aba therapy this will continue in conjunction with 
the other more traditional forms of therapy. 
Currently, ST, OT, and PT are considered traditional treatment plans for autism and thus 
private insurance providers are now required to cover them.
78
 After much contention, ABA 
therapy is also now required to be covered. All of these treatments seek to improve the 
symptoms, which impair the functional lives of people with autism through.
79
 Still, none of these 
treatments address the underlying cause of the symptoms, the neurological malfunction. 
Biomedical Treatment for ASD involves physiological analysis and treatment.
80
 Many 
professionals believe that there is a strong correlation between the neurological impairments of a 
child with ASD and the digestive issues common for a child with ASD.
81
 The biomedical 
approach involves assessing the overall physical function of the child through testing their blood 
and stool for deficiencies in certain nutrients and identifying any substances that should not be 
there such as heavy metals or overproduction of candida.
82
 After testing, children are often 
placed on strict diets to account for any food sensitivities they may have, as well as, prescribed 
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nutritional supplements in order to counteract any deficiencies identified.
83
  Occasionally, the 
use of psychotropic drugs to address symptoms of ADHD is used in conjunction with other 
biomedical treatments.
84
  The goal of biomedical treatment is to purify the body to allow for 
optimal cellular function so the body can heal itself. Currently, biomedical treatment is not 
covered by private insurance providers.
85
 
Distinguishable from biomedical treatments are homeopathic approaches, which include, 
acupuncture, music therapy, and dog therapy.
86
 These approaches are merely supplemental and 
should not be used to replace the other therapies discussed above. These approaches are not 
medical as they do not address the underlying causes of the impairment and do not change 
cellular function or body chemistry of the child.  Further, the cost of these approaches tends to 
be minimal and their effect is more to encourage emotional well-being.
87
 These avenues of 
treatment are typically excluded by insurance providers.
88
 Biomedical treatment should not be 
considered part of this group of alternative treatment as biomedical approaches actually change 
the chemical composition of the child’s body and biomedicine is implemented and monitored by 
a physician.  
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While, neither a preventative strategy, nor a cure for autism has been discovered, early 
intervention involving a combination of the above referenced therapies has shown to 
significantly reduce the symptoms and impairments inflicting children with ASD, thus allowing 
these “recovered” children to lead relatively independent adult lives. More expansive insurance 
coverage should be provided to children with ASD. 
C. IMPACT OF AUTISM: HIGH HOPES LEAD TO LARGE DEBT. 
While the benefits of biomedical treatment for children diagnosed with PDD-NOS will 
only help a small subset of the population, the negative impact of excluding this treatment from 
health insurance coverage is immense. Overall, treating autism is a heavy financial burden, 
running as much as $72,000 for one child per year, or over 3.2 million over the course of that 
child’s lifespan.89  If insurance providers are required to allocate this cost more evenly across the 
entire pool of insured, it will only slightly increase rates but the benefit is significantly helping 
the individual families effected by ASD.
90
 One study revealed that total expenditures per 10,000 
covered lives associated with ASDs increased 142.1% over a 5-year period.
91
  With costs of care 
rising annually, and the current cost of treating a child with ASD, this is a significant amount of 
money for a family to have to pay. One family even admits that in ten years the cost of their sons 
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treatments for ASD toppled one million dollars.
92
  While the average cost of treating a child with 
ASD is 3 to 5 million per child, this cost can be reduced by two thirds by implementing 
appropriate early intervention.
93
  By helping children who have ASD but are high functioning, 
like the sub population of children with PDD-NOS, we can significantly reduce the total lifespan 
cost for children with ASD. 
Specifically, biomedical treatment should be covered by insurance providers because the 
treatment is beneficial and will result in lowering the overall cost of caring for a child with ASD 
because they will progress faster in their development. Also, requiring insurance coverage for 
biomedical treatment is important because the treatment can be very costly for a family to have 
to pay out of pocket. One study conducted by, “retrospective analysis of private health insurance 
claims,” revealed that the average health care expenditures in annual inpatient, outpatient, and 
prescription drug expenditures for children under seventeen with an ASD increased 20.4% from 
$4,965 per patient in 2000, to $5,979 per patient in 2004.
94
 Many families have started to ask 
family, friends, and even strangers to help donate to help pay for biomedical treatments for their 
child with ASD.
95
  Without insurance coverage, families will not be able to access appropriate 
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early intervention for their children and thus the cost of caring for that child will remain high 
throughout adulthood. 
Early therapeutic intervention for ASD is the key difference between developing into an 
adult needing full-time care and an adult capable of living an independent productive life 
without expensive aide.  Thus, even though these treatments may be expensive, they are well 
worth the cost early in life, because they will increase the possibility that the child with PDD-
NOS will be independent as an adult, able to hold a job and be self-sustaining therefore reducing 
their economic dependence on the system as a whole.
96
  Caring for a child with ASD is a social 
concern and the financial burden should be shared accordingly. This cost should not be left to 
the families that happen to have a child with autism because society as a whole is universally 
vulnerable to autism.  Thus, the benefit to mandating insurance coverage for biomedical 
treatments for ASD is that it will protect the insured so they can effectively find a treatment plan 
that their child responds to, and in turn, can achieve a greater level of overall health and less 
reliance on costly treatments in the long run.  
II. BIOMEDICAL TREATMENT IS EFFECTIVE IN TREATING PDD-NOS.  
Treating ASD with biomedicine is based on the application of the principals of natural 
science to clinical practices through physiological interventions, which reduce the symptoms 
associated with one's inability to tolerate environmental stressors.
97
  Such treatments seek to 
treat the child individually and holistically, addressing imbalances with medical or chemical 
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means.
98
 The biomedical approach to ASD aims to address the genetic, epigenetic, and 
biochemical issues that are the underlying causes of the child’s symptoms.”99 Epigenetics 
studies the changes in DNA expressions which cause impairments when the underlying DNA 
sequence has not changed.
100
 ASD’s are thought to be caused by a genetic mutation that occurs 
during prenatal development possibly triggered by environmental factors.  Thus, environmental 
factors may be what has significantly impacted the DNA to cause it to express itself differently 
when there is no specific genetic reason (DNA sequence is not different).
101
  Environmental 
insults (at this point specific causes are unknown but believe to be a combination of chemicals, 
metals, radiation, and preservatives) lead to biochemical changes manifesting themselves 
through behavioral impairments and result in a vicious cycle of developmental delays.
102
 
Treating ASD with a biomedical approach aims to interrupt the cycle in an effort to restore 
proper cell function.
103
  
Biomedical treatment alleviates digestive problems, which are common to children with 
ASD, and by altering their body chemistry to reduce many impairing social and cognitive 
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symptoms.
104
 Particularly, using biomedical treatments for Autism involves removing 
environmental toxins present in the body and repairing any damage which has resulted.
105
  
Biomedical treatment for ASD typically includes treatment of food sensitivities by employing 
special diet plans (such as gluten free casine free diet), treating vitamin deficiencies with 
supplements (deficiencies in amino acids and detoxifying the body of metals), and even 
pharmaceuticals (to treat symptoms of hyperactivity).
106
 
Specifically, food sensitivity has been linked to improper bodily processes, thus by 
identifying which foods are causing reactions and eliminating those from the diet some children 
show improvement in overall functioning (including the improvement of cognitive ability).
107
 
This is supported by empirical data provided by multiple studies. One United Kingdom study 
showed positive development in children with ASD put on gluten and casein-free diets 
(GFCF).
108
  Additional studies prove that daily supplements of vital nutrients, such as those 
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containing amino acids, often effectively reduce symptoms associated with ASD, because they 
are converted into neurotransmitters, which can alleviate mental disorders caused by chemical 
imbalances in the brain such as depression. 
109
 One study in particular conducted on a 9-year-old 
boy with autism proved he responded positively to the nutritional supplements, Dimethylglycine 
and a combination of a large dose of Vitamin B6 (Pyridoxal HCl) and Magnesium.
 110
 Still, the 
reported findings from this study cannot be generalized because every child may react 
differently or need a different combination of supplements. A case study on an individual child 
such as this provides preliminary evidence enhancing an accumulating body of literature 
supporting the theory and efficacies of nutritional supplements in ASDs.
111
 Further, a  
randomized, double-blind, placebo-controlled study conducted over a three month period 
administered vitamin and mineral treatment to 141 children and adults with ASD showed that 
the supplement group had significantly greater improvements than the placebo group on the 
Parental Global Impressions-Revised, which showed decreased hyperactivity, less tantrumming, 
and increased ability in receptive language.
 112
  This suggests that vitamin and mineral 
                                                          
109
 Ibrahim KS, El-Sayed EM. Proposed remedies for some developmental disorders. Toxicol Ind Health. 2012 Feb 
2. Available at, http://www.ncbi.nlm.nih.gov/pubmed/22301819. 
110
 Xia RR. Effectiveness of nutritional supplements for reducing symptoms in autism-spectrum disorder: a case 
report.  J Altern Complement Med. 2011 Mar;17(3):271-4. Source Department of Physical Therapy, Creighton 
University, available at, http://www.ncbi.nlm.nih.gov/pubmed/21417812. Two family members independently 
administered the The Autism Treatment Evaluation Checklist (ATEC) at baseline and at 5 moths into treatment to 
gauge improvement.  The ATEC evaluates four areas: communication, sociability, sensory/cognitive awareness, 
and behavior. The lower the scores are, the less severe the symptoms are. The ATEC evaluations showed that the 
changes in total ATEC were from 63 at pretest to 33 at post-test, and from 64 at pretest to 30 at post-test, 
respectively. These changes represented reductions of 47.6% and 53.1%. The school teachers also noticed 
improvements in various areas consistent with the ATEC evaluations. 
111
 Id. 
112
 Adams JB, et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011 
Dec 12;11:111. Autism/Asperger's Research Program, Arizona State University, Tempe, available at 
http://www.ncbi.nlm.nih.gov/pubmed/22151477. Vitamin/mineral supplementation is beneficial in improving the 
nutritional and metabolic status of children with autism, including improvements in methylation, glutathione, 
Harper 24 
 
supplement are a reasonable and effective course of therapy to consider for most children and 
adults with ASD.
113
 Nutritional supplements have proven effective for treating ASD for specific 
children, but biomedical treatment goes beyond just nutritional assessment and treatment. 
Pharmaceutical interventions, have also proven a useful biomedical approach.  
Supporting this, the article Therapies for Children with Autism Spectrum Disorder synthesized 
data from medical studies conducted from January 2000 to May 2010 the results of which 
determined antipsychotic drugs Risperidone and Aripiprazole aide improvement in “challenging 
behavior that includes emotional distress, aggression, hyperactivity, and self-injury.”114 Some of 
the cases in the above referenced study revealed some mild side effects (emphasized as not 
being significant). Still, the results supports the use of medical intervention as a part of an early 
intensive behavioral and developmental plan to improve cognitive performance, language skills, 
and adaptive behavior in children with ASD.  
These studies provide a basis for linking biomedical treatments to symptom reduction for 
ASD. Still, in order to require private insurance companies to cover biomedical treatment more 
studies will need to be done in order for biomedical treatments to be sufficiently accepted in the 
medical community to require coverage. Otherwise sufficient studies will need to be done to 
provide enough empirical evidence to show that despite not being accepted as treatment it 
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should be covered because the data shows it is effective and safe. Additional studies are 
currently being conducted with results soon to be released.
 115
 
III. PRIVATE INSURANCE PROVIDER’S STRONGEST ARGUMENTS FOR EXCLUDING 
BIOMEDICAL TREATMENT FROM COVERAGE.   
 
“What is it about the little boy; 
he acts different in every way 
What is it about the little boy; 
they say it won’t go away 
 
What is it about the little boy? 
What is the cause for concern? 
What it is about the little boy, 
has a diagnosis we’ve learned 
 
Now we know about the little boy 
So now where do we turn? 
Now we know about the little boy; 
there is so much to learn 
 
So, who will help the little boy? 
Insurance says no way! 
Who will help the little boy 
If we cannot pay?”116 
 
Private health insurance may be governed through federal legislation, ERISA or through 
state regulation of smaller employers.
117
 ASD has been explicitly included in the mental health 
parity law as a neurological disorder which requires coverage by insurance providers.
118
 
Nonetheless, Insurance coverage is not absolute. In many cases insurance coverage is restricted 
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to particular services, preferred health care providers, and can also have annual monetary 
limits.
119
 Further, private insurance providers often limit coverage to statutory mandates which 
set the minimum for emergency care, preventative care, and chronic illness care.
120
 
Unfortunately, many private insurance plans are allowed to create major loopholes, which 
insurance providers use to deny insurance coverage for many treatments. Insurance Providers 
exclude ASD treatments claiming them to be Complementary and Alternative Medicine and not 
medically necessary.
121
 
A. INSURANCE PROVIDERS EXCLUDE COVERAGE FOR BIOMEDICAL TREATMENT BY CLAIMING IT IS 
“COMPLIMENTARY ALTERNATIVE MEDICINE” (CAM).  
Insurance providers avoid coverage by claiming services are Complementary and 
Alternative Medicine (CAM).  CAM is defined as, “a group of diverse medical and health care 
systems, practices, and products that are not presently considered to be part of conventional 
medicine.”122    
 Typical exclusions of CAM treatments involve acupuncture, massage, hypnotherapy, and 
probiotics.
123
 Private insurance carriers have been allowed the freedom to exclude many useful 
medical treatments under this broad exclusion. This reallocation of medical expenditure has 
heavily burdened individual citizens. According to the American Hospital Assoc., in 2007 US 
consumers spent 33.9 billion out-of-pocket for CAM including both the purchase of CAM 
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products and materials as well as the estimated 354.2 million visits to CAM practitioners.
124
  
Additionally, even hospitals which primarily focus on emergency and terminal illness are 
increasing the availability of typical CAM services in house, as well as, increasing their referrals 
for CAM treatments.
125
   Insurance providers trying to prevent additional costs for treatments for 
ASDs have a stronger argument in excluding music therapy or dog therapy (even though both of 
these have proven effective in reaching a child with ASD), than they do with blocking 
biomedical treatment administered by an Medical Doctor. 
B. INSURANCE PROVIDERS EXCLUDE BIOMEDICAL TREATMENT FROM COVERAGE BY CLAIMING IT 
IS NOT “MEDICALLY NECESSARY.” 
A common provision in health insurance policies is to require that covered services, 
equipment or supplies be medically necessary.
126
 Conversely, services that are not medically 
necessary are excluded from coverage.
127
 If the terms of the contract are unambiguous as to how 
the insurance provider defines a medically necessary treatment then the treatment is evaluated 
according to the terms of the contract. For example, some policies define "medically necessary" 
as a service or treatment in accordance with accepted medical standards in the area, which 
services could not be omitted without an adverse effect on the patient.
128
 If, on the other hand, 
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the contract is ambiguous then the contract will be strictly interpreted in favor of the insured and 
will consider safety and efficacy to determine if the treatment is a covered benefit.
129
  
To determine if a treatment is medically necessary, the courts will first consider the 
terms of the policy and the nature of the treatment.
 130
 To evaluate the nature of the treatment, 
the court may consider; appropriateness of the level or intensity of the service, the individual 
patients condition and if the request treatment is appropriate to treat that condition, and whether 
the therapy is “merely performance enhancing or discretionary in nature.”131 The court will also 
consider if the terms of the contract are clear and unambiguous. 
One example of an insurance policy attempting to define medical necessity gives the 
insured’s the right, “to have a candid discussion about appropriate or medically necessary 
treatment options for your condition, regardless of cost or benefit coverage.”132 While it is 
beneficial to know about medically necessary treatment options by ones doctor, if they are not 
going to be covered by the insurance provider, the discussion itself does the patient little good. 
Still, the plan also provides insured’s the right to receive medically necessary specialty care,133 
and allows the insured to request a waiver for medically necessary prescriptions that are not 
covered under the plan.
134
 To determine if a treatment of service is medically necessary, this 
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plan has medical staff comprised of physicians, registered nurses and other health care providers 
that “review requests for health care services to determine if the requested service is medically 
necessary.”135 The plan fails to provide a specific rubric or the actual consideration the medical 
staff uses in order to make such a determination. 
Further, in April 2000, Aetna (one of the largest health insurance providers), agreed to a 
settlement contract that stipulated medically necessary as, 
"health services and supplies that under the applicable standard of care are 
appropriate: (a) to improve or preserve health, life, or function; or (b) to slow the 
deterioration of health, life, or function; or (c) for the early screening, prevention, 
evaluation, diagnosis or treatment of a disease, condition, illness or injury." 
Included in this definition is the cost effectiveness of services and supplies. A 
treatment is cost effective if it is the least expensive medically necessary 
treatment selected from two or more treatments that are "equally effective."
136
  
This definition would provide for great leeway in arguing that biomedical treatment for 
autism is a cost effective way to change their overall function, improve their health, and 
ultimately reduce costs of their services in the future. As there is no standard legislative 
definition of the term medically necessary, all therapies will be considered by assessing the 
terms of the contract.  
Still, in the absence of a definition for medically necessary treatment in the plan, or when 
there is an ambiguity in the terms of the plan, courts will adopt their own assessment for what is 
                                                          
135
 Id. at 12 
136
 Brown E. Medically necessary? Physician Exec. 1999 Mar-Apr;25(2):74-6. Available at, 
http://www.ncbi.nlm.nih.gov/pubmed/10351736. See also, Glossary. Aetna. Available at, 
https://www.aetnastudenthealth.com/stu_conn/glossary.aspx#M. (“Medically necessary services or supplies that are 
appropriate for or consistent with the diagnosis according to accepted medical standards as described in the Covered 
Benefits section of the plan.”). 
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a medically necessary and thus covered treatment under that particular plan. The second circuit 
adopted an individual assessment of medically necessary procedures positing,  
“unless the contrary is specified, the term “medical necessity” must refer to what 
is medically necessary for a particular patient, and hence entails an individual 
assessment rather than a general determination of what works in the ordinary 
case.”137 
Some courts have determined that, “medical necessity is strictly a contractual term in 
which a patient’s physician must prove that a procedure is medically appropriate and 
efficacious.”138 Other courts have defined medical necessary as, “a treatment that is commonly 
recommended, or not outside the mainstream of the usual customary practice of medicine, or 
meets the common standard of care.”139  
IV. MODALITIES FOR LAWYERS ADVOCATING FOR COVERAGE FOR THEIR CLIENTS. 
Insurance providers try to escape coverage for ASD treatments by claiming they are not 
medically necessary and/or that they are experimental. In order for advocates to successfully 
convince the judiciary that biomedical treatment for ASDs should be covered by private 
insurance providers, advocates must prove that the treatment is either accepted in the medical 
community as a legitimate treatment and/or that the treatment is beneficial and not dangerous.  
Advocates seeking to expand benefits that children with ASD receive should emphasize 
the public policy behind protecting this vulnerable class of people. “Exclusion of [health benefit] 
                                                          
137
 Janet L. Kaminski. Defining Medical Necessity. OLR Research Report. February 23, 2007. Available at, 
http://www.cga.ct.gov/2007/rpt/2007-r-0055.htm. 
138
 Morris A. Landau. The Difficulties in Defining Medical Necessity. University of Houston Law Center. 
November 29, 2000. Available at, http://www.law.uh.edu/healthlaw/perspectives/Managed/001129Difficulties.html. 
139
 Whitehead v. Federal Express Corp., 878 F. Supp. 1066 (W.D. Tenn. 1994).  
Harper 31 
 
coverage based solely because of [a] disability is against legislative intent.”140 While there is 
currently no mandate that explicitly requires insurance carriers to cover biomedical treatment, 
denying children with ASD access to this treatment is contrary to public interest. “Every child is 
born with the potential to develop those skills necessary to life in society.
141
 Children afflicted 
with ASD cannot achieve their full potential without a comprehensive treatment plan specific to 
their individual needs, and biomedical treatments have become an essential part of such a plan. 
Early intense treatments can help restore children with ASDs’ potential.142 The court in, 
Micheletti v. State Health Benefits Comm'n, further posited that when a treatment is not exotic 
nor economically wasteful it should be covered.
143
  Further, the court emphasized that including 
treatment for a small number of children with ASD would not necessary overly burden the 
provider or the entire community of insured.
144
 It is important for advocates to remember the 
vulnerability of the population seeking treatment, the fact that the cost of covering them will not 
be overly burdensome on the insurance provider or on the population of insured overall, and that 
it is the intent of the legislature to protect the rights of those inflicted with lifelong impairments 
such as ASD. 
Advocates seeking remedy in the judicially for biomedical treatment coverage will likely 
be facing an insurance provider that claims biomedical treatment is excluded under the policies 
                                                          
140
 Micheletti v. State Health Benefits Comm'n, 913 A.2d 842, 844 (App. Div. 2007). 
 
141
 Id. (“developmental defines childhood”). 
142
 Id. 
143
 Id. (the necessity of the speech and occupational therapy treatment in this case was not disputed). 
144
 Murray v. State Health Benefits Comm'n, 767 A.2d 509, 510 (App. Div. 2001). (The plaintiff sought 
reimbursement of 170 dollars for colonic hydrotherapy which was excluded under the experimental provisions of 
the contract, although similar to an enema which is covered by the insurance it was different in the administration of 
the procedure). 
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CAM provision. Many policies consider treatments, which are not common or “outside the 
prevailing opinion within the appropriate specialty,” to be complimentary, and thus excluded.145 
Also, if treatments are still in the clinical trials or research stages and being used as educational 
tools then providers typically try to exclude the treatment as CAM as well.
146
 Where the terms of 
the contract are not ambiguous as to what constitutes an experimental treatment, and the 
treatment in question is in phase II clinical trial or less and the insured signs a consent form, 
which specifically states the treatment is for research and/or is experimental the insurance 
company was not required to cover this treatment.
147
 Exclusions under CAM were originally 
allowed in order to ensure safety and efficacy of treatments. Yet, courts have recognized that the 
use of alternative medical treatments is expanding, and thus they should not be excluded from 
insurance coverage without careful consideration. If treatments are commonly accepted among 
alternative medicine practitioners they should not be excluded solely because “traditional 
doctors do not yet utilize the treatment or are completely unfamiliar with the practice.”148 This 
                                                          
145
 Id. 
146
 Parsons v. Sisters of Charity of Leavenworth Health Sys., Inc., 2011 WL 2144894 (D. Mont. May 31, 2011). 
Coverage for a treatment that was proven partially successful through clinical trials was denied for a twenty year 
old suffering from a chronic autoimmune disease with no cure called Crohn’s disease, which attacks the 
gastrointestinal tract. Several reasons to conclude this treatment was in fact experimental (peer review article stating 
randomized studies needed to be conducted still, partial approval of the procedure by FDA not full, the consent 
letter for the clinical trial explicitly stated that it was an experimental research study, and severe possibility of 
serious health risks with the procedure).
 
In order to enter into the clinical trial the plaintiff was required to sign a 
consent form which contains specific language stating it was an agreement to participate in an “experimental 
research study” which involves a “risky” procedure which “may not work” and may “result in death.” The consent 
form also state that even though this procedure was full approved by the FDA for some transplants for cancer it was 
not approved for the treatment of crohns disease yet, thus it was not standard within the medical community for this 
purpose.   
147
 Murray v. State Health Benefits Comm'n, 767 A.2d 509, 510 (App. Div. 2001). 
148
 Id. See also, Michael H. Cohen, Holistic Health Care: Including Alternative and Complementary Medicine in 
Insurance and Regulatory Schemes, 28 Ariz.L.Rev. 83, 156 (1996). “Insurer inclusion of alternative and 
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growing acceptance for CAM treatments is exhibited by medical schools, which now teach 
alternative approaches to accompany traditional medical practices.
149
 Another consideration in 
evading CAM exclusions is that if the alternative treatment is potentially dangerous for the 
patient the court likely proceed with caution and require more studies before ruling the treatment 
must be covered by insurance.
150
 This is not a concern with biomedical treatment. Biomedical 
treatment does not have significant side effects that would cause a court to take pause in 
determine the safety of the treatments. Further, any proposed therapy must be viewed in its 
entirety to discern whether the treatment qualifies as experimental.
151
 The courts have much 
difficulty in determining if a treatment should be considered experimental and thus excludable 
as they are recognizing that alternative treatments can be cost effective and as medicine 
continues with new innovation the courts have more difficulty in denying coverage for more 
efficient and more economic treatments.
152
 
                                                                                                                                                                                          
complementary therapies is likely to expand as therapies gain acceptance and credibility, and gain support by data 
showing that such treatment can contribute to health so as to minimize insurers' overall costs.” 
149
 Kathleen M. Boozang, Western Medicine Opens the Door to Alternative Medicine, 24 Am.J.L. & Med. 185, 
186-187 (1998). “As more doctors are taught these techniques the availability and utilization of alternative 
treatments will increase.” 
150
 Id. at 514-15. (“there was sufficient evidence for the Commission to conclude that this particular 
treatment was potentially unsafe and inefficacious for the purposes prescribed, and it was not 
error to consider the gastroenterologist as the “appropriate specialty” to determine whether this 
particular treatment requires further evaluation.”). 
151
 Kopicki v. Fitzgerald Auto. Family Employee Benefits Plan, 121 F. Supp. 2d 467, 469-70 (D. Md. 2000). See 
also, Hendricks and Martin. 39 F.3d at 514–515. Id. at 477. 
152 Vellios v. IPRO, External Review Agent, 765 N.Y.S.2d 222, 223 (Sup. Ct. 2003). (In order to resolve 
whether new alternative treatments should be covered by insurance, “the prudent course of action might be 
to establish some sort of regional cooperative committees comprised of oncologists, internists, surgeons, 
experts in medical ethics, medical school administrators, economists, representatives of the insurance 
industry, patient advocates and politicians. Through such a collective task force perhaps some consensus 
might be reached concerning the definition of experimental procedures, as well as agreement on the 
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Advocates need to convince the court that despite having yet to be proven efficacious it 
is in the public’s best interest for insurance providers to cover biomedical treatment.153 Typically 
the plaintiffs’ burden of proof in trying to obtain coverage under a perspective insurance plan 
requires that the plaintiff fulfill the “medically necessary” provision. Occasionally, insurance 
providers will explicitly enumerate requirements for a treatment to be medically necessary. The 
determination of coverage should not be based solely on the “likelihood of success” but instead 
should be a balance between the irreparable harm to the plaintiff against the harm to the 
defendant and if the balance goes towards the plaintiff the likelihood of success test is 
displaced.
154
 The position of the Health Care Financing Administration (HCFA) on the 
procedure may also factor into the analysis.
155
 As a final element or consideration, “public 
interest favors the preservation of life and a patient receiving medical benefits to which he is 
entitled.”156  
Advocates should emphasize to the court that private insurance providers’ decisions to 
exclude coverage are given less discretion then state benefits providers. State benefits plans are 
                                                                                                                                                                                          
procedures, which are so cost prohibitive that requiring insurers to cover them might result in the collapse 
of the healthcare industry.” Article 49 of the Insurance Law, determinations of health care plans to deny 
coverage for medical treatment to their insureds’.”). 
 
153
 Fuja v. Benefit Trust Life Ins. Co., 18 F.3d 1405, 1407 (7th Cir. 1994).  
154
Kopicki v. Fitzgerald Auto. Family Employee Benefits Plan, 121 F. Supp. 2d 467, 479-80 (D. Md. 2000). See 
also, Blackwelder Furn., 550 F.2d at 194. 
155
 Id. 476. 
156
 Id.. (quoting), Accord Dozsa v. Crum & Forster Ins. Co., 716 F.Supp. 131, 140 (D.N.J.1989). (“In Wilson, the 
court found that the total absence of Phase III clinical trials on the therapy in question did not justify a categorical 
determination that such a procedure was experimental or investigational. 65 F.3d at 365–66. Rather, the court found 
that “a therapy could become standard practice in the medical community before it had been proven more effective 
than traditional treatment ....where a highly promising treatment for a terminal illness is known to be harmless, but 
has yet to be proven efficacious in prospective, randomized testing.” Wilson, 65 F.3d at 366. Id. 481.”). 
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provided more discretion for limiting or excluding coverage as necessary to “avoid inequity and 
unnecessary utilization.”157 Courts have recognized that state health plans and commercial 
insurance plans are distinguishable because the state commission “must balance its obligations 
of meeting the health care needs of its members with a fiduciary obligation to make the program 
cost effective.”158 Private insurance carriers do not have the incentive to keep the program cost 
effective. Consequently, ambiguous provisions will be construed against commercial policies as 
an adhesion contract (unlike deference given to state plan administrative decisions).”159  
Additionally, the court will limit the discretion given to insurance provider’s decisions to 
exclude treatment when there is a conflict of interest. A conflict of interests exists if the plan 
administrator is given sole authority to review and make decisions on plan terms and on benefit 
coverage determinations.
160
 When there is a conflict of interest, ambiguities are to be construed 
against the insurers.
161
 
Biomedical treatment for autism does have a place in the insurance provider’s coverage 
plan. There have been randomized tests done that show that biomedical treatment can be 
effective in treating ASDs. Additionally, there is a movement towards acceptance of alternative 
                                                          
157
 Markiewicz v. State Health Benefits Comm'n., 915 A.2d 553, 561  (App. Div. 2007). (arbitrary and 
capricious review of decisions). 
158
 Id. 
159
Murray v. State Health Benefits Comm'n, 767 A.2d 509, 511 (App. Div. 2001) (quoting) Heaton v. State Health 
Benefits Comm'n, 624 A.2d 69 (App.Div.1993). see also, Kievit v. Loyal Protective Life Ins. Co., 170 A.2d 22 
(1961). Thus, for commercial plans the insurance providers decision to exclude experimental treatments will not be 
given as much discretion by the courts, providing plaintiffs with a lower threshold to prove the private insurance 
companies decisions to exclude was wrong. 
160
 Kopicki v. Fitzgerald Auto. Family Employee Benefits Plan, 121 F. Supp. 2d 467, 473 (D. Md. 2000). See also, 
Killian v. Healthsource Provident Administrators, Inc., 152 F.3d 514, 521 (6th Cir.1998) (finding when an 
employer “both funds and administers the plan at issue, there is an actual and apparent conflict.”). 
161
 Id. at 475. (referencing) Bailey v. Blue Cross/Blue Shield of Virginia, 866 F.Supp. 277 (E.D.Va.1994). 
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medicine, in particular holistic approaches to alleviating impairing physiological symptoms. 
Considering that there is a lower differential standard for private insurance companies than the 
one given to state insurance, the judiciary should require private insurance carriers to cover 
biomedical treatment for children with ASDs. 
Advocates attempting to get judicially mandated coverage for biomedical treatment for 
ASDs by private insurance carriers have an uphill battle. Advocates should emphasize the public 
interest in protecting the rights to comprehensive treatment benefits, of children with ASD, as 
they are a vulnerable community. They should also emphasize that providing children with ASD 
better treatment will reduce the overall costs of caring for them, as they will require less services 
as they continue to progress developmentally.  Further, by ensuring such treatment for children 
with PDD-NOS who are typically higher functioning, they possibly can become completely 
independent as adults.  As more clinical studies come out, advocates must prove that the 
treatment is accepted in the medical community as a legitimate treatment. Further, advocates 
should emphasize that the treatment is beneficial and not dangerous and thus should be covered 
even if it has not yet been accepted by mainstream medicine. 
V. POSSIBLE LEGISLATIVE REFORM. 
Biomedical treatment will have a relatively low cost per child but can have a cumulative 
heavy burden on insurance companies. Additionally, treatment is extremely individualized and 
may or may not work for any individual child. Thus, insurance providers are reluctant to cover 
this expense. Regardless of insurance providers resistance, the rise in ASD has prompted federal 
and state mandates expanding insurance coverage for ASD treatments to expand.
162
  Further, 
                                                          
162
 Justine Redmen. Mom Wins Fight For Autism Insurance. CNN.com. Available at, 
http://www.cnn.com/2008/HEALTH/conditions/04/01/autism.insurance/index.html. See also, South Carolina: 
Frequently Asked Questions About the Autism Insurance Reform Law (Ryan’s Law). Available at, 
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once additional clinical trials are conducted on biomedical approaches to reduce ASD 
symptoms, insurance companies will eventually be required to cover the cost of these treatments 
as biomedical approaches for ASD become more widely accepted in the mainstream medical 
community or as the empirical evidence clearly shows a health benefit and no dangerous side 
effects.  
One possible approach to achieving mandated coverage would be to propose legislation 
similar to that of Ryan’s Law but instead of advocating for ABA therapy, the new legislation 
would explicitly require biomedical treatment for ASD to be coverage by private insurance.
163
 A 
compromising limitation could be to set yearly limitations on the amount the insurance provider 
will cover towards biomedical treatments.
164
 Another possible requirement would be for 
insurance companies pay for initial testing, with a referral from the primary care physician, to 
determine if that particular child requires or would benefit from biomedical treatment. Moving 
forward, if the doctor at the initial visit/testing phase recommends a course of action then those 
subsequent treatment expenses will be required to be covered up to the annual policy limit. 
Many state legislatures so far have also included age limits suggesting mandatory coverage up 
until a certain age.
165
 Possibly adding a simple sentence to these already implemented mandates 
to include coverage nutritional supplements and medications would also be beneficial. For new 
state mandates, an age limit for biomedical treatment coverage is not beneficial because children 
                                                                                                                                                                                          
http://ddsn.sc.gov/providers/medicaidwaiverservices/pdd/Documents/PDDManual/Ryan%27s%20Law%20FAQ.pd
f 
163
 Id. 
164
 For visitation limits see, N.J. Admin. Code 11:4-57.3. For Coverage limits see, N.J. Stat. Ann. § 17B:27-46.1ii 
(West). 
165
 Tex. Ins. Code Ann. § 1355.015 (West). (coverage from date of diagnosis until the age of nine). See also, Alaska 
Admin. Code tit. 7, § 135.220 ( coverage for those “under 21 years of  age with a severe behavioral disorder”). 
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likely will still need this treatment as their symptoms increase and decrease as the child goes 
through various life stages. A beneficial proposal to expand coverage may read: 
  “At a minimum, a health benefit plan must provide coverage as provided by this 
section to an enrollee who is diagnosed with autism spectrum disorder:”166 
 
(1) initial testing by a specialist for biomedical treatments for autism 
including but not limited to blood and stool testing for food 
sensititivies, digestive track issues, testing for chemical 
imbalances, testing for vitamin deficiencies, and any test that is 
prescribed in order to access and implement biomedical treatment. 
 
(2) Physician recommended medications or nutritional supplements 
used to address symptoms of autism spectrum disorder.
167
 
  
(3) Comprehensive testing/evaluations to reassess the child’s progress, 
to cover at least two comprehensive tests/evaluations per year (one 
comprehensive test every six months). The specialist shall have the 
discretion to determine, which tests shall be conducted for the bi-
annual evaluations. The specialist will have the ability to 
test/evaluate more frequently than twice per year.  
 
“The benefits provided pursuant to this subsection shall be provided to the same 
extent as for any other medical condition under the policy,” and cannot be 
excluded as being non-restorative, except that the provider may implement certain 
exclusions and/or requirements such as:
168
 
 
(A) Treatment limits for biomedical treatments of $10,000 per year. 
 
(B) Require a prescription for the visit to the specialist by the primary 
care physician.
169
 
                                                          
166
 Tex. Ins. Code Ann. § 1355.015 (West). 
167
 Id. 
168
 N.J. Stat. Ann. § 17B:27-46.1ii (West). (“The benefits provided pursuant to this subsection shall not be denied 
on the basis that the treatment is not restorative.”). 
169
 N.J. Admin. Code 11:4-57.3 (preauthorization requirement). 
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(C) Limit the amount of visits to the nutritional specialist to 20 visits 
per year and can count phone consultations that the doctor charges 
as a visit in the visitation limit.
170
 
 
(D) Providers may choose to only cover the initial specialist visit and 
testing and upon recommendation with explanation from the 
specialist the provider will then be required to cover the 
recommended course of action including (2) form this subsection 
up until any explicit treatment limits in section (A) of this 
subsection. 
 
Legislative reform for biomedical treatment is a distant reality considering more clinical 
studies need to be done in order to have enough evidence that this treatment is successful, that is 
it not harmful, and that it is accepted in the medical community.
171
 Still, a basic proposal similar 
to the one posited above seems to be a fair compromise between the needs of children with ASD 
and the needs of insurance providers to keep expenses low. A mandate similar to this will 
require children with ASD to be allowed to at least get initial testing to see if they may benefit 
from a biomedical treatment program and ensure that if the specialist determines they will 
benefit, that the insurance provider will cover up to 10,000 in expenses towards the treatment 
annually.  While this may not cover the complete cost of biomedical treatment for every child 
with ASD, it is certainly a major help to families who are currently paying completely out of 
pocket for their children’s biomedical treatment. Further, this proposal protects insurance 
providers interests by allowing an annual limit, and limiting the amount of comprehensive 
                                                          
170
 Id. (annual visitation limits allowed). 
171
 Dreher W. Evidence-based medicine and public health law: statutory health insurance. Z Arztl Fortbild 
Qualitatssich. 2004 Sep;98(6):489-93. Available at, http://www.ncbi.nlm.nih.gov/pubmed/15527192. Positing that 
quality of medical services should be a consideration in determining if a treatment is medically necessary, and that 
quality of services is the main concern of Evidence-based Medicine (EbM). 
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testing to twice annually. Ultimately, a proposal like this will help to make biomedical treatment 
an accessible treatment option for children with ASD, thus allow children with ASD to  access 
to a more comprehensive treatment plan earlier in life so they can achieve larger developmental 
gains and have lower health care costs throughout their lives, which should be the ultimate goal 
of health insurance reform for this vulnerable population. 
VI. CONCLUDING THOUGHTS: BIOMEDICAL TREATMENT IS A USEFUL MEDICAL 
TREATMENT THAT SHOULD BE COVERED BY INSURANCE IN ACCORDANCE WITH THE 
PUBLIC POLICY OF PROVIDING ACCESS TO BENEFICIAL TREATMENT THAT IS NOT 
DANGEROUS. 
Children with developmental disabilities are the most vulnerable community in our 
society and should receive the highest level of protection, and the most significant access to 
health care. ASD is unpredictable, it crosses socioeconomic boundaries and it can cause severe 
impairments, which significantly reduces life opportunities for many children. Thus, expanding 
coverage to help this community is the obligation of society as a whole. Particularly children 
diagnosed with PDD-NOS have the potential to lead independent and productive adult lives but 
they experience very real barriers to their physical, educational, and social development. If there 
is a possibility those barriers can be alleviated through biomedical treatment, the small cost is 
worth the great gain, the life of a child. 
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